Literature DB >> 2654344

IgA nephropathy associated with chronic hepatitis B virus infection in adults: the pathogenetic role of HBsAG.

K N Lai1, F M Lai, J S Tam.   

Abstract

Five adult cases of IgA nephropathy associated with chronic hepatitis B virus infection were studied. Serum HBsAg and anti-HBc were present in five patients and HBeAg in four patients. Glomerular changes were typical of primary IgA nephropathy in four patients, and a mixed picture of IgA and membranous nephropathy was demonstrated in one patient. Immunofluorescence microscopy using polyclonal and monoclonal antibodies against HBsAg, HBcAg, and HBeAg revealed mesangial deposits of HBsAg in renal biopsies from four patients. One renal biopsy showed only mesangial and capillary HBcAg by polyclonal antiserum, and virus-like particles were demonstrated in the intramembranous electron-dense deposits on ultrastructural examination. Mesangial HBeAg was not detected in the renal biopsies from these patients with IgA nephropathy. As for the single patient with a mixed picture of IgA and membranous nephropathy, granular deposits of HBeAg with a distribution similar to IgG were detected in the glomerular capillary walls in addition to the mesangial deposition of HBsAg. These findings suggest that HBsAg rather than HBeAg may play a role of the pathogenesis in some of the adult patients with IgA nephropathy associated with chronic hepatitis B virus infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654344     DOI: 10.1002/path.1711570409

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  6 in total

1.  Immunohistochemical study of the membrane attack complex of complement and S-protein in idiopathic and secondary membranous nephropathy.

Authors:  K N Lai; S T Lo; F M Lai
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

2.  Immunopathology of glomerulonephritis associated with chronic woodchuck hepatitis virus infection in woodchucks (Marmota monax).

Authors:  D N Peters; H Steinberg; W I Anderson; W E Hornbuckle; P J Cote; J L Gerin; R M Lewis; B C Tennant
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.

Authors:  Li-Jing Sun; Jian-Ping Shan; Ruo-Lan Cui; Wei-Jie Yuan; Geng-Ru Jiang
Journal:  Int Urol Nephrol       Date:  2017-03-10       Impact factor: 2.370

4.  The frequency of hepatitis B virus infection in Greek patients with various types of glomerulonephritis.

Authors:  L Nakopoulou; K Stefanaki; P M Zeis; J Boletis; J Papadakis; G Vosnides; P Davaris
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

5.  Circulating HBsAg/IgG complexes in idiopathic chronic glomerulonephritis.

Authors:  S Y Hong; D H Yang; J M Park
Journal:  Korean J Intern Med       Date:  1991-01       Impact factor: 2.884

6.  Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study.

Authors:  Zhaoping Yan; Bing Qiao; Haifeng Zhang; Yanling Wang; Wei Gou
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.